This afternoon our CSO Joana Cardoso Vaz takes the stage at XIII Jornadas do Centro Hepato-Bilio-Pancreático e de Transplantação 🎤 Join us today for her insightful talk on "Biomarkers and Machine Learning: New Selection Criteria for Transplant and Resection in Hepatocellular Carcinoma". 📍 After the talk, stop by our booth to keep the conversation going, meet our team, and explore our latest advancements. Let’s continue pushing forward with innovative, impactful solutions together💡 #Ophiomics #HepatoPredict #LiverCancer #HCC #LiverPrecisionMedicine #CHBPT #Biomarkers #Machinelearning #AI
Sobre nós
Science-enabled Precision Oncology
- Site
-
http://www.ophiomics.com
Link externo para Ophiomics
- Setor
- Pesquisa biotecnológica
- Tamanho da empresa
- 11-50 funcionários
- Sede
- Lisboa
- Tipo
- Empresa privada
- Fundada em
- 2015
- Especializações
- precision medicine, genomics, bioinformatics, cancer e machine learning
Localidades
-
Principal
Rua Cupertino de Miranda, N9 – Lote 8
Lisboa, 1600-513, PT
Funcionários da Ophiomics
-
Sergio Faria
CFO
-
André João Folgado
Operations Manager
-
Joana Cardoso Vaz
Founder & CSO of Ophiomics; Bio/Medtech R&D researcher; Promoter of Genomic Education for non-scientists
-
Ana Mateus Chocalheiro
Regulatory Affairs & Quality Assurance Manager @ Ophiomics | Biochemist | Quality Management | ISO 9001 | ISO 13485
Atualizações
-
📢 We will be attending the XIII Jornadas do Centro Hepato-Bilio-Pancreático e de Transplantação showcasing HepatoPredict, our innovative prognostic tool designed to support clinical decisions for liver transplantation in patients with Hepatocellular Carcinoma 🩺✨ Come visit us to learn how HepatoPredict can help advance care for patients with Hepatocellular Carcinoma. Let’s work together toward a brighter future for liver health! 💪 #Ophiomics #HepatoPredict #LiverCancer #HCC #LiverPrecisionMedicine #CHBPT
-
📣 October is Liver Cancer Awareness Month🎗 ! 👉 Follow us and visit our website to discover innovative diagnostic solutions and learn how we’re committed to improving liver health . #livercancer #LiverCancerAwarenessMonth #HCC #Ophiomics #HepatoPredict #precisionlivermedicine References: (1) International Agency for Research on Cancer. Liver Cancer fact sheet (2022) (2) Rumgay H et al. Global burden of primary liver cancer in 2020 and predictions to 2040. J Hepatol. 2022;77:1598–606.
-
Ophiomics compartilhou isso
Sayonara Biojapan 2024, see you next year! It was great to meeet old and new friends, and to discuss avenues for collaboration with Japanese (and beyond) partners. Thank you EU-Japan Centre for Industrial Cooperation for the opportunity and all the support. Kampai!
-
We're #hiring a new Financial And Administrative Manager in Lisbon. Apply today or share this post with your network.
-
Ophiomics compartilhou isso
-
Ophiomics compartilhou isso
Ophiomics is present at #EASLCongress 2024 in Milan. Visit us at Booth bt3 to learn everything about our prognostic tool on liver cancer #HepatoPredict. Is is being a fantastic meeting!😃
-
I am very proud to announce that our poster entitled “Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict”, that was accepted for #EASLCongress, was selected for oral presentation today at the Track Hub: General Hepatology! It was fantastic to talk about our tool #HepatoPredict to such an audience!😃
-
Ophiomics is present at #EASLCongress 2024 in Milan. Visit us at Booth bt3 to learn everything about our prognostic tool on liver cancer #HepatoPredict. Is is being a fantastic meeting!😃
-
Lets connect in Munich https://www.health.tech/
Páginas semelhantes
Financiamento
Última rodada
Série AUS$ 6.478.768,00
Investidores
BlueCrow Capital